Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease
by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi
Updated on: June 28,2024
5

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease
by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi
Updated on:June 28,2024
5
